Back to Woodline Partners LP Woodline Partners LP

CTMXCTMX
8 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in CYTOMX THERAPEUTICS INC.

Woodline Partners LP holds 2M shares of CTMX (CYTOMX THERAPEUTICS INC.), worth $7.7M as of 2026-Q2. The position was increased (+2.0% shares). CTMX represents 0.0% of Woodline Partners LP's portfolio.

Current Value

$7.7M

Current Shares

2M

Total Value Change

+$7.2M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2M
+2.0%
$7.7M0.0%$3.75
28
2026-Q1
Decreased
2M
-14.4%
$9.4M0.0%$4.81
0
2025-Q4
Unchanged
2.3M
0.0%
$10M0.0%$4.16
0
2025-Q3
Increased
2.3M
0.0%
$7.5M0.0%$3.23
27
2025-Q2
Increased
2.3M
+41.0%
$5.3M0.0%$2.25
36
2025-Q1
New
1.7M
-
$1.1M0.0%$0.63
35
2024-Q4
Exited
0
-100.0%
$00.0%$1.02
0
2024-Q3
New
393,832
-
$464,7220.0%$1.20
33

Other major holders of CTMX: FMR LLC, BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used